Skip to main content

Advertisement

SpringerLink
Log in

Glucocorticoid and mineralocorticoid resistance

  • Views
  • Facts, perspectives and opinions on selected topics
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Rererences

  1. Dallman M.R., Akana S.F., Cascio C.S., Darlington D.N., Jacobson L., Levin N. Regulation of adrenocorticotrophic hormone secretion: variations on a theme of B. Rec. Prog. Hor. Res. 43: 113, 1987.

    CAS  Google Scholar 

  2. Arriza J.L., Weinberger C., Cerelli G., Glaser T.M., Handelin B.L., Housman D.F., and Evans R.M. Cloning of the human mineralocorticoid receptor complementary DNA: Structural and functional kinship with the glucocorticoid receptor. Science 237: 268, 1987.

    PubMed  CAS  Google Scholar 

  3. Wade J.B., Stanton B.A., Field M.J., Kashgarian M., Giebisch G. Morphological and physiological responses to aldosterone: time course and sodium dependence. Am. J. Physiol. 259: F88, 1990.

    PubMed  CAS  Google Scholar 

  4. El. Mernissi G., Chabardes D., Doucet A., HusCitharel A., Imbert-Teboul M., Le Bouffant F.J. Montegut M., Siaume S., Morel F. Changes in tubular basolateral membrane markers after chronic DOCA treatment. Am. J. Physiol. 245: F100, 1983.

    PubMed  CAS  Google Scholar 

  5. Hays S.R. Mineralocorticoid modulation of apical and basolateral membrane H+/OH-/HCO-3 transport processes in the rabbit inner stripe of outer medullary collecting duct. J. Clin. Invest. 90: 180, 1992.

    PubMed Central  PubMed  CAS  Google Scholar 

  6. Kuwahara M., Sasaki S., Marumo F. Mineralocorticoids and acidosis regulate H+/HCO3-transport of intercalated cells. J. Clin. Invest. 89: 1388, 1992.

    PubMed Central  PubMed  CAS  Google Scholar 

  7. Marver D., Kokko J.P. Renal target sites and the mechanism of action of aldosterone. Miner. Electrolyte Metab. 9: 1, 1983.

    PubMed  CAS  Google Scholar 

  8. El Mernissi G., Barlet-Bas C., Khadouri L., Cheval S.M., Doucet A. Short-term effect of aldosterone on vasopressin-sensitive adenylate cyclase in rat collecting tubule. Am. J. Physiol. 264: F821, 1993.

    PubMed  Google Scholar 

  9. Jenkins H.R., Fenton T.R., McIntosh N., Dillon M.J., Milla P.J. Development of colonic sodium transport in early childhood and its regulation by aldosterone. Gut 31: 194, 1990.

    PubMed Central  PubMed  CAS  Google Scholar 

  10. Bastl C.P., Schulman G., Cragoe E.J. Jr. Glucocorticoids inhibit colonic aldosterone-induced conductive Na+ absorption in adrenalectomised rat. Am. J. Physiol. 263: F443, 1992.

    PubMed  CAS  Google Scholar 

  11. Fromm M., Schulzke J.D., Hegel U. Control of electrogenic Na+ absorption in rat late distal colon by nanomolar aldosterone added in vitro. Am. J. Physiol. 264: E68, 1993.

    PubMed  CAS  Google Scholar 

  12. Rechkemmer G., Halm D.R. Aldosterone stimulates K secretion across mammalian colon independent of Na absorption. Proc. Nat. Acad. Scie. (USA) 86: 397, 1989.

    CAS  Google Scholar 

  13. Perrone R.D., Nye J.P., McBride D.E., Zahniser D.J., Geyer J.J., Ucci A.A. Aldosterone induces apical vesicles in rat distal colon. Am. J. Physiol. 259: F65, 1990.

    PubMed  CAS  Google Scholar 

  14. Dillon M.J., Gillin M.E.A., Ryness J.M., de Swiet M. Plasma renin activity and aldosterone concentration in the human newborn. Arch. Dis. Child. 51: 537, 1976.

    PubMed Central  PubMed  CAS  Google Scholar 

  15. Gonzalez-Campoy J.M., Romero J.C., Knox F.G. Escape from the sodium retaining effects of mineralocorticoids: role of ANF and intrarenal hormone systems. Kidney International 35: 767, 1989.

    PubMed  CAS  Google Scholar 

  16. Hollenberg S.M., Weinberger C., Ong E.S. Primary structure and expression of a functional human glucocorticoid receptor cDNA. Nature 318: 63541, 1985.

    Google Scholar 

  17. Giguere V., Hollenberg S.M., Rosenfeld M.G., Evans R.M. Functional domains of the human glucocorticoid receptor. Cell 46: 645, 1986.

    PubMed  CAS  Google Scholar 

  18. Arriza J.L., Simerly R.B., Swanson L.W., Evans R.M. Neuronal mineralocorticoid receptor as a mediator of glucocorticoid response. Neuron 1: 887, 1988.

    PubMed  CAS  Google Scholar 

  19. Pearce D., Yamamoto K.R. Mineralocorticoid and glucocorticoid receptor activities distinguished by nonreceptor factors at a composite response element. Science 259: 1661, 1993.

    Google Scholar 

  20. Adler A.J., Danielsen M., Robins D.M. Aldosterone-specific gene activation via a consensus glucocorticoid response element is determined by interaction with nonreceptor factors. Proc. Nat. Acad. Sci. (USA) 89: 11660, 1992.

    CAS  Google Scholar 

  21. Rennie P.S., Bruchovsky N., Leco K.J. Characterisation of two cis-acting DNA elements involved in the androgen regulation of the probasin gene. Mol. Endocrinol. 7: 23, 1993.

    PubMed  CAS  Google Scholar 

  22. Rupprecht R., Arizza J.L., Spengler D. Transactivation and synergistic properties of the mineralocorticoid receptor: relationship to the glucocorticoid receptor. Mol. Endocrinol. 7: 597, 1993.

    PubMed  CAS  Google Scholar 

  23. Encio I.J., Detera-Wadleigh S.D. The genomic structure of the human glucocorticoid receptor. J. Biol. Chem. 266: 7182, 1991.

    PubMed  CAS  Google Scholar 

  24. Zennaro M.C., Keightley M.C., Kotelevtsev Y., Conway G.S., Soubrier F., Fuller P.J. Human mineralococrtoicoid receptor genomic structure and identification of expressed isoforms. J. Biol. Chem. (In press), 1995.

  25. Kwak S.P., Patel P.D. Thompson R.C., Akil H., Watson S.J. 5′ heterogeneity of the mineralocorticoid receptor messenger ribonucleic acid: differential expression and regulation of splice variants within the rat hippocampus. Endocrinol 133: 2344, 1993.

    CAS  Google Scholar 

  26. Krozowski Z.S., Funder J.W. Renal mineralocorticoid receptors and hippocampal corticosterone binding species have identical intrinsic steroid specificity. Proc. Nat. Acad. Sci. (USA) 80: 6056, 1983.

    CAS  Google Scholar 

  27. Edwards C.R.W., Stewart P.M., Burt D. Localization of 11ß-hydroxysteroid dehydrogenase — tissue specific protector of the mineralocorticoid receptor. Lancet 2: 986, 1988.

    PubMed  CAS  Google Scholar 

  28. Funder J.W., Pearce P.T., Smith R., Smith A.I. Mineralocorticoid action: targetissue specificity is enzyme, not receptor-mediated. Science 242: 583, 1988.

    PubMed  CAS  Google Scholar 

  29. Albiston A.L., Obeyesekere V.R., Smith R.E., Krozowski Z.S. Cloning and tissue distribution of the human 11ß-hydroxysteroid dehydrogenase type 2 enzyme. Mol. Cell. Endocrinol. 105: R11, 1994.

    PubMed  CAS  Google Scholar 

  30. Mercer W.R., Krozowski Z.S. Localization of an 11ß-hydroxysteroid dehydrogenase activity to the distal nephron of the rat kidney. Evidence for the existence of two species of dehydrogenase in the rat kidney. Endocrinology 130: 540, 1992.

    CAS  Google Scholar 

  31. Lakshmi V., Monder C. Purification and characterization of the corticosteroid 11ß-dehydrogenase component of the rat liver 11ß-hydroxysteroid dehydrogenase complex. Endocrinology 123: 2390, 1989.

    Google Scholar 

  32. Agarwal A.K., Monder C., Ecksten B., White P.C. Cloning and expression of a rat cDNA encoding corticosterone 11ß-dehydrogenase. J. Biol. Chem. 264: 18939, 1989.

    PubMed  CAS  Google Scholar 

  33. Tannin G.M., Agarwal A.K., Monder C., New M.I., White P.C. The human gene for 11ß-hydroxysteroid dehydrogenase. Structure, tissue distribution and chromosomal localization. J. Biol. Chem. 266: 16653, 1991.

    CAS  Google Scholar 

  34. McEwen B.S., Lambdin L.T., Rainbow T.C., DeNicola A.F. Aldosterone efects on salt appetite in adrenalectomized rats. Neuroendocrinology 43: 38, 1986.

    PubMed  CAS  Google Scholar 

  35. Joels M., de Kloet E.R. Mineralocorticoid receptor-mediated changes in membrane properties of rat CA1 pyramidal neurons in vitro. Proc. Nat. Acad. Sci. (USA) 87: 4495, 1990.

    CAS  Google Scholar 

  36. de Kloet E.R., Versteeg D.H.G., Kovacs G.L. Aldosterone blocks the response to corticosterone in the raphe-hippocampal serotonin system. Brain Res. 264: 323, 1983.

    PubMed  Google Scholar 

  37. de Kloet E.R., Sybesma H., Reul J.H.M. Selective control by corticosterone of serotonin-1 receptor capacity raphe-hippocampal system. Neuroendocrinology 42: 513, 1986.

    PubMed  Google Scholar 

  38. Trapp T., Rupprecht R., Castren M., Reul J.M., Holsboer F. Heterodimerization between mineralocorticoid and glucocorticoid receptor: a new principle of glucocorticcoid action in the CNS. Neuron 13: 1457, 1994.

    PubMed  CAS  Google Scholar 

  39. Wehling M., Christ M., Theisen K. Membrane receptors for aldosterone: a novel pathway for mineralocorticoid action. Am. J. Physiol. 263: E974, 1992.

    PubMed  CAS  Google Scholar 

  40. Wehling M., Christ M., Thiesen K. High affinity aldosterone binding to plasma mem; brane rich fractions from mononuclear leukocytes: is there a membrane receptor for mineralocorticoids? Biochem. Biophys. Res. Commun. 181: 1306, 1991.

    CAS  Google Scholar 

  41. Wehling M., Eisen C., Aktas J., Theisen K., Christ M. The inositol-1,4,5-trisphosphate system is involved in rapid nongenomic effects of aldosterone in human mononuclear leukocytes. Exp. Clin. Endocrinol. 101: 109, 1993

    Google Scholar 

  42. Dalman F.C., Scherrer L.C., Taylor L.P. Localisation of the 90 kDa heat shock protein-binding site within the hormone binding domain of the glucocorticoid receptor by peptide competition. J. Biol. Chem. 266: 3482, 1991.

    PubMed  CAS  Google Scholar 

  43. Ku Tai P.K., Albers M.W., Chang H. Association of 59kDa immunophilin with the glucocorticoid receptor complex. Science 256: 1315, 1992.

    Google Scholar 

  44. Picard D., Yamamoto K.R. Two signals mediate hormone-dependent nuclear localisation of the glucocorticoid receptor. EMBO J. 6: 3333, 1987.

    PubMed Central  PubMed  CAS  Google Scholar 

  45. Weigel N.L., Carter T.H., Schrader W.T., O’Malley B.W. Chicken progesterone receptor is phosphorylated by a DNA-dependent protein kinase during in vitro transcription assays. Mol. Endocrinol. 6: 8, 1992.

    PubMed  CAS  Google Scholar 

  46. Rafestin-Oblin M.E., Couette B., Radanyi C., Lombes M., Bauiieu E.E. Mineralocorticoid receptor of the chick intestine. Oligomeric structure and transformation. J. Biol. Chem. 264: 9304, 1989.

    CAS  Google Scholar 

  47. Binart N., Lombes M., Rafestin-Oblin M.E., Baulieu E.E. Characterization of the human mineralocorticosteroid receptor expressed in the baculovirus system. PNAS 88: 10681, 1994

    Google Scholar 

  48. Lombes M., Binart N., Oblin M.E., Joulin V., Bauiieu E.E. Characterization of the interection of the human mineralocorticosteroid receptor with hormone responsive elements. Biochem. J. 292: 577, 1993.

    PubMed Central  PubMed  CAS  Google Scholar 

  49. Schafer JA, Hawk C.T. (1992). Regulation of Na+ channels in the cortical collecting duct by AVP and mineralocorticoids. Kidney Int. 41: 255, 1992.

    CAS  Google Scholar 

  50. Kemendy A.E., Kleyman T.R., Eaton D.C. Aldosterone alters the open probability of amilorideblockable sodium channels in A6 epithelia. Am. J. Physiol. 263: C825, 1992.

    PubMed  CAS  Google Scholar 

  51. Minuth W.W., Steckelings U., Gross P. Complex physiological and biochemical action of aldosterone in toad urinary bladder and mammalian renal collecting duct cells. Renal Physiology 10: 297, 1987.

    CAS  Google Scholar 

  52. Canessa C.M., Schild L., Buell G. Amiloride-sensitive epithelial Na+ channel is made of three homologous subunits. Nature 367: 412, 1994.

    Google Scholar 

  53. Shimkets R.A., Warnock D.G., Bositis C.M., et al. Liddle’s syndrome: heritable human hypertension caused by mutations in the beta subunit of the epithelial sodium channel. Cell 79: 407, 1994.

    PubMed  CAS  Google Scholar 

  54. Lamberts, S.W.J., Koper, J.W., Biemond, P., Den Holder, F.H., and De Jong, F.H. Cortisol receptor resistance: The variability of its clinical presentation and response to treatment. J. Clin. Endocrinol. Metab. 74: 313, 1992.

    PubMed  CAS  Google Scholar 

  55. Huizenga A.T.M., Molijn G.J., de Jong F.H., Lamberts S.W.J., Koper J.W. The dexamethasone suppression test and the analysis of glucocorticoid sensitivity. J. Endocrinol. 144: 347 (abstract), 1995.

    Google Scholar 

  56. Vingerhoeds A., Thijssen J., Shwarz F. Spontaneous hypercortisolism without Cushing’s syndrome. J. Clin. Endocrinol. Metab. 43: 1128, 1976.

    PubMed  CAS  Google Scholar 

  57. Lamberts S.W.J., Poldermans D., Zweens M., de Jong F.H Familial cortisol resistance. Differential diagnostic and therapeutic aspects. J. Clin. Endocrinol. Metab. 63: 1328, 1986.

    PubMed  CAS  Google Scholar 

  58. Lipsett M., Tomita M., Brandon D. Cortisol resistance in man. Adv. Exp. Biol. 196: 97, 1986.

    CAS  Google Scholar 

  59. Chrousos G.P., Gold P.W. The concept of stress and stress system disorders: overview of behavioural and physical homeostasis. J. Am. Med. Assoc. 267: 1244, 1992.

    CAS  Google Scholar 

  60. Moalli P.A., Pillay S., Weiner D., Leikin R., Rosen S.T. Mechanism of resistance to glucocorticoids in multiple myeloma; transient expression of a truncated glucocorticoid receptor mRNA. Blood 79: 213, 1992.

    PubMed  CAS  Google Scholar 

  61. Sher E.R., Leung D.Y., Surs W. Steroid resistant asthma. Cellular mechanisms contributing to inadequate response to glucocorticoid therapy. J. Clin. Invest. (U.S.) 93: 33, 1994.

    CAS  Google Scholar 

  62. Norbiato G., Bevilacqua M., Vago T. Cortisol resistance in acquired immunodeficiency syndrome. J. Clin. Endocrinol. Metab. 74: 608, 1992.

    PubMed  CAS  Google Scholar 

  63. Cheek D.B., Perry J.W. A salt wasting syndrome in infancy. Arch. Dis. Child. 33: 252, 1958.

    PubMed Central  PubMed  CAS  Google Scholar 

  64. Cessans C., Berthier M., Bonneau D., Millet C., Mettey R. Congenital pseudohypoaldosteronism: apropos of 6 cases. Pediatrie 44: 649, 1989.

    PubMed  CAS  Google Scholar 

  65. Kuhnle U., Nielsen M.D., Tietze H-U., Schroeter C.H., Schlamp D., Bosson D., Knorr D., Armanini D. Pseudohypoaldosteronism in eight families: different forms of inheritance are evidence for various genetic defects. J. Clin. Endocrinol. Metab. 70: 638, 1990.

    PubMed  CAS  Google Scholar 

  66. Proesmans W., Geussens H., Corbeel L., Eeckels R. Pseudohypoaldosteronism. Am. J. Dis. Child. 126: 510, 1973.

    PubMed  CAS  Google Scholar 

  67. Speiser P.W., Stoner E., New M.I. Pseudohypoaldosteronism: A review and report of two new cases. Adv. Exp. Med. Biol. 196: 173, 1986.

    PubMed  CAS  Google Scholar 

  68. Royer P., Bonnette J., Mathieu H., Gabilan J-C., Klutchko G., Zittoun R. Pseudo-hypoaldosteronisme. Ann. Pediatr. 39: 596, 1963.

    Google Scholar 

  69. Yasuda T., Noda-Cho H., Nishioka T., Sasaki N., Niini H., Nakajima H. Pseudohypoaldosteronism: decreased aldosterone levels with age without significant change in urinary sodium excretion. Clin. Endocrinol. (Oxf). 24: 311, 1986.

    PubMed  CAS  Google Scholar 

  70. Butenandt I., Dorr H.G., Kuhnle U. Pseudohypoaldosteronism — renal salt loss syndrome. Therapy and course exemplified in 2 siblings. Monatsschr. Kinderheilkd. 134: 544, 1986.

    CAS  Google Scholar 

  71. Popow C., Pollak A., Herkner K., Scheibenreiter S., and Swoboda W. Familial pseudohypoaldosteronism. Acta. Paediatr. Scand. 77: 136, 1988.

    PubMed  CAS  Google Scholar 

  72. Hogg R.J., Marks J.F., Marver D., Frolich J.C. Long term observations in a patient with pseudohypoaldosteronism. Pediatr. Nephrol. 5: 205, 1991.

    PubMed  CAS  Google Scholar 

  73. Rodriguez-Soriano J., Ubetagoyena M., Vallo A. Transtubular potassium concentration gradient: a useful test to estimate renal aldosterone bio-activity in infants and childrens. Pediatr. Nephrol. 4: 105, 1990.

    PubMed  CAS  Google Scholar 

  74. Koopman B.J., Lockerse I.J., Verveij H., Nagel G.T., van der Molen J.C., Drayer N.M., Wolthers B.G. Improved gas chromatographic-mass fragmentographic assay for tetrahydroaldosterone and aldosterone in urine. J. Chromatogr. 378: 283, 1986.

    PubMed  CAS  Google Scholar 

  75. Rosler A. The natural history of salt-wasting disorders of adrenal and renal origin. J. Clin. Endocrinol. Metabl. 59: 689, 1984.

    CAS  Google Scholar 

  76. Sugawara M., Lebron B.A., Calabria, R. Pseudohypoaldosteronism following resection of ileum and colon. Nephron. 57: 567, 1989.

    Google Scholar 

  77. Rodriguez-Soriano J., Vallo A., Qunitella M.J., Oliveros R., Ubetagoyena M. Normokalaemic pseudohypoaldosteronism is present in childeren with acute pyelonephritis. Acta. Paediatr. 81: 402, 1992.

    PubMed  CAS  Google Scholar 

  78. Escribano Burgos C., Lopez-Herce Cid J., Sala Juaniz I., Dorao Martinez-Romillo P., Delgado Dominguez M.A.,Espinosa Roman L. Salt losing tubulopathy secondary to urinary infection: a form of transitory pseudohypoaldosteronism. An. Esp. Pediatr. 30: 404, 1989.

    PubMed  CAS  Google Scholar 

  79. Eisenstein B., Davidovitz M., Garty B.Z., Shmueli D., Ussim A., Stark H. Severe tubular resistance to aldosterone in a child with familial juvenile nephrolithiasis. Pediatric Nephrology 6: 57, 1992.

    PubMed  CAS  Google Scholar 

  80. Nieto J., Gutierrez Millet V., Gutierrez Roderp F., Miranda B., Alcazar J.M., Bello I., Ruilope L.M., Rodicio J.L. Pseudohypoaldosteronism associated with chronic interstitial nephropathy. Rev. Clin. Esp. 177: 290, 1995.

    Google Scholar 

  81. Uribarri J., Oh S., Butt H., Carrol J. Pseudohypoaldosteronism following kidney transplantation. Nephron. 31: 368, 1982.

    PubMed  CAS  Google Scholar 

  82. Kowarski A.A., Migeon C.J., Aldosterone in childhood. Juvenile Hypertension, (Ed.) New MI, Levine LS. Raven Press, NY, pp. 97, 1977.

  83. Siegler R.L., Crouch R.H., Hackett T.N., Walker M., Jubiz W. Potassium-reninaldosterone relationships during the first year of life. J. Paediatr. 91: 52, 1977.

    CAS  Google Scholar 

  84. Dillon M.J., Gillin M.E.A., Ryness J.M., de Swiet M. Plasma renin activity and aldosterone concentration in the human newborn. Archives of Disease in Childhood 51: 537, 1976.

    PubMed Central  PubMed  CAS  Google Scholar 

  85. Paver W.K.A., Pauline G.J. Hypertension and hyperpotassiumaemia in a young male without renal disease. Med. J. Aus. 2: 305, 1964.

    CAS  Google Scholar 

  86. Spitzer A., Edelmann C.M. Jr, Goldberg L.D., Henneman P.H. Short stature, hyperkalemia and acidosis: A defect in renal transport of potassium. Kidney Int. 3: 251, 1973.

    PubMed  CAS  Google Scholar 

  87. Schambelan M., Sebastian A., and Rector Jr. F.C. Mineralocorticoid resistant renal hyperkalaemia without salt wasting (type II pseudohypoaldosteronism): Role of increased renal chloride reabsorption. Kidney Int. 19: 716, 1981.

    PubMed  CAS  Google Scholar 

  88. Take C., Ikeda K., Kurasawa T., Kurokawa K. Increased chloride reabsorption as an inherited renal tubular defect in familial Type II pseudohypoaldosteronism. New Engl. J. Med. 324: 472, 1991.

    PubMed  CAS  Google Scholar 

  89. Licht J.H., Amundson D., Hsueh W.A., Lombardo J.V. Familiar hyperkalaemic acidosis. Quarterly J. Med. 54: 161, 1985.

    CAS  Google Scholar 

  90. Armanini, D., Wehling, M., Da Dalt L., Zennaro M., Scali U., Keller U., Pratesi C., Mantero F., Kuhnle U. Pseudohypoaldosteronism and mineralocorticoid receptor abnormalities. J. Steroid. Biochem. Mol. Biol. 40: 363, 1991.

    PubMed  CAS  Google Scholar 

  91. Hanukoglu A. Type I pseudohypoaldosteronism includes two clinically and genetically distinct entities with either renal or multiple target organ defects. J. Clin. Endocrinol. Metab. 73: 936, 1991.

    PubMed  CAS  Google Scholar 

  92. Bosson D., Kuhnle U., Mees N., Ramet J., Vamos E., Vertongen F., Wolter R. Generalised unresponsiveness to mineralocorticoid hormones: familial recessive pseudohypoaldosteronism due to aldosterone receptor deficiency. Acta. Endocrinol. Suppl. (Copenh). 279: 376, 1986.

    PubMed  CAS  Google Scholar 

  93. Wehling M., Khuls S., Armanini D. Volume regulation of human lymphocytes by aldosterone in isotonic media. Am. J. Physiol 257: E170, 1989

    PubMed  CAS  Google Scholar 

  94. Chitayat D., Spirer Z., Ayalon D., Golander A. Pseudohypoaldosteronism in a female infant and her family: diversity of clinical expression and mode of inheritance. Acta. Paediatr. Scand. 74: 619, 1985.

    PubMed  CAS  Google Scholar 

  95. Oberfield S.E., Levine L.S., Carey R.M., Bejar R., New M.I. Pseudohypoaldosteronism: multiple target organ unresponsiveness to mineralocorticoid hormones. J. Clin. Endocrinol. Metab. 48: 228, 1979.

    PubMed  CAS  Google Scholar 

  96. Roy C. Pseudohypoaldosteronisme familiale. Arch. Franc. Ped. 34: 37, 1977.

    CAS  Google Scholar 

  97. Bommon M., Brook C.G. Pseudohypoaldosteronism. Response to long-term management with indomethacin. Arch. Dis. Child. 57: 718, 1982.

    Google Scholar 

  98. Werder E.A., Hilbe W., Vallotton M.B. Prostaglandin excretion in pseudohypoaldosteronism type I. Acta. Endocrinol. Suppl. (Copenh) 279: 381, 1986.

    CAS  Google Scholar 

  99. Bronnegard M., Werner S., Gustasfsson J.A. Primary cortisol resistance associated with a thermolabile glucocorticoid receptor in a patient with fatigue as the only symptom. J. Clin. Invest. 78: 1270, 1986.

    PubMed Central  PubMed  CAS  Google Scholar 

  100. Chrousos G.P., Vingerhoeds A.C., Loriaux D.L., Lipsett M.B. Primary cortisol resistance: a family study. J. Clin. Endocrinol. Metab. 56: 1243, 1983.

    PubMed  CAS  Google Scholar 

  101. Leung D.Y., Martin R.J., Szefler S.J. Dysregulation of interleukin 4, interleukin 5 and interferon gamma gene expression in steroid-resistant asthma. J. Exp. Med. (U.S.) 181: 33, 1955.

    Google Scholar 

  102. Kam J.C., Szefler S.J., Surs W., Sher E.R., Leung D.Y. Combination of IL-2 and IL-4 reduces glucocorticoid receptor-binding affinity and T cell response to glucocorticoids. J. Immunol. (U.S.) 151: 3460, 1993.

    CAS  Google Scholar 

  103. Hurley D.M., Accili D., Stratakis C.A., Karl M., Vamvakopoulos N., Rorer E., Constantine K., Taylor S.I., Chrousos G.P. Point mutation causing a single amino acid substitution on the hormone binding domain of the glucocorticoid receptor in familial glucocorticoid resistance. J. Clin. Invest. 87: 680, 1991.

    PubMed Central  PubMed  CAS  Google Scholar 

  104. Karl M., Lamberts S.W., Detera-Wadleigh SD.. Familial glucocorticoid resistance caused by a splice site deletion in the human glucocorticoid receptor gene. J. Clin. Endocrinol. Metab. 76: 683, 1993.

    CAS  Google Scholar 

  105. Malchoff D.M., Brufsky A., Rearda G. A mutation of the glucocorticoid receptors in primary cortisol resistance. J. Clin. Invest. 91: 1918.

  106. Keightley M.C., Fuller P.J. Unique sequences in the guinea pig glucocorticoid receptor induce constitutive transactivation and decrease steroid sensitivity. Mol. Endocrinol. 8: 431, 1994.

    PubMed  CAS  Google Scholar 

  107. Moore C.C., Mellon S.H., Murai J., Siiteri P.K., Miller W.L. Structure and function of the hepatic form of 11 beta-hydroxysteroid dehydrogenase in the squirrel monkey, an animal model of glucocorticoid resistance. Endocrinology 133: 368, 1993.

    PubMed  CAS  Google Scholar 

  108. Fuller P.J., Funder J.W. Mineralocorticoid and glucocorticoid receptors in human kidney. Kidney International 10: 154, 1976.

    PubMed  CAS  Google Scholar 

  109. Matulich D.T., Spindler B.J., Schambelan M., Baxter J.D. Mineralocorticoid receptors in human kidney. J. Clin. Endocrinol. Metab. 43: 1170, 1976.

    PubMed  CAS  Google Scholar 

  110. Postel-Vinay M-C., Alberti G.M., Ricour C., Limai J-M., Rappaport R., Royer P. (1974) Pseudohypoaldosteronism: persistence of hyperaldosteronism and evidence for renal tubular and intestinal responsiveness to endogenous aldosterone. J. Clin. Endocrinol. Metab. 39: 1038, 1974.

    PubMed  CAS  Google Scholar 

  111. Herkner K., Pollak A., Swoboda W., Holler B. Explanation of the pseudohypoaldosteronism (PHA)-stress syndrome with an artificial aldosterone receptor model. J. Steroid Biochem. 20: 317, 1984.

    PubMed  CAS  Google Scholar 

  112. Armanini D., Strasser T., Weber P.C. Characterization of aldosterone binding sites in circulating human mononuclear leukocytes. Am. J. Physiol. 248: E388, 1985.

    PubMed  CAS  Google Scholar 

  113. Armanini D., Kuhnle U., Strasser T., Dorr H., Butenandt I., Weber P.C., Stockigt J.R., Pearce P., Funder J.W. Aldosterone-receptor deficiency in pseudohypoaldosteronism. N. Engl. J. Med. 313: 1178, 1985.

    PubMed  CAS  Google Scholar 

  114. Zennaro M.C., Borensztein P., Jeunemaitre X., Armanini D., Soubrier F. No alteration in the primary structure of the mineralocorticoid receptor in a family with pseudohypoaldosteronism. J. Clin. Endocrinol. Metab. 79: 32, 1994.

    PubMed  CAS  Google Scholar 

  115. Komesaroff P.A., Verity K., Fuller P.J. Pseudohypoaldosteronism: molecular characterisation. J. Clin. Endocrinol. Metab. 79: 27, 1994.

    PubMed  CAS  Google Scholar 

  116. Komesaroff P.A., Funder J.W., Fuller P.J. Mineralocorticoid Resistance. In Sheppard and Stewart eds. Hormone-nuclear receptor interactions in health and disease Clin. Endocrinol. Metab. 8: 333, 1994

    CAS  Google Scholar 

  117. Arai K., Tsigos C., Suziki Y. Physiological and molecular aspects of mineralocorticoid receptor action on pseudohypoaldosteronism: a responsiveness test and therapy. J. Clin. Endocrinol. Metab. 79: 1019, 1994.

    PubMed  CAS  Google Scholar 

  118. Arai K., Chrousos G.P. Glucocorticoid resistance. In Sheppard and Stewart (eds) Hormone-nuclear receptor interactions in health and disease. Clin. Endocrinol. Metab. 8: 317, 1994.

    CAS  Google Scholar 

  119. Arai K., Tsigos C., Suzuki Y. No apparent mineralocorticoid receptor defect in a series of sporadic cases of pseudohypoaldosteronism. J. Clin. Endocrinol. Metab. 80: 814, 1995.

    PubMed  CAS  Google Scholar 

  120. Armanini D., Witzgall H., Wehling M., Kuhnle U., Weber P.C. Aldosterone receptors in different types of primary hyperaldosteronism. J. Clin. Endocrinol. Metab. 65: 101, 1987.

    PubMed  CAS  Google Scholar 

  121. Gacad M.A., Adams J.S. Endogenous blockade of 1,25-dihydroxyvitamin D receptor binding in New World primate cells. Endocrinology 131: 2581, 1992.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Baker Medical Research Institute, Prahran, Victoria, Australia, 3181

    P. A. Komesaroff

  2. Faculté de Médecine X. Bichat, INSERM U 246, Paris, France

    M. C. Zennaro

Authors
  1. P. A. Komesaroff
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. C. Zennaro
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Komesaroff, P.A., Zennaro, M.C. Glucocorticoid and mineralocorticoid resistance. J Endocrinol Invest 18, 550–564 (1995). https://doi.org/10.1007/BF03349767

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03349767

Keywords

Search

Navigation